• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$20.20 $0.08 (0.40%)

REAL-TIME: Last trade at

Warner Chilcott Ltd.

NASDAQ:WCRX

WCRX, Watson Pharma in Legal Tussle - Analyst Blog

Mylan Raises 2012 Earnings Guidance - Analyst Blog

Warner Chilcott Tops But Cuts View - Analyst Blog

Warner Chilcott Beats Up on Analysts Yet Again

US STOCK FUTURES: HOT STOCKS TO WATCH

Why Warner Chilcott Shares Popped... Again

2nd UPDATE: Warner Chilcott Confirms Strategic Review; In Talks With Potential Suitors

Why Warner Chilcott's Shares Popped

Zacks.com featured expert Kevin Matras highlights: Agrium Inc., Brookfield Properties corp., Dynex C

Wrinkled Bladder? There's a Drug for That!

Revenues Slip at Warner Chilcott - Analyst Blog

Warner Chilcott Beats Analyst Estimates on EPS

WCRX's 2012 Outlook Disappoints - Analyst Blog

Watson's Drug Fails to Get Support - Analyst Blog

US Stock Futures: HOT STOCKS TO WATCH

US Stock Futures: HOT STOCKS TO WATCH

How to Inflation-Proof Your Portfolio

Let's Check Salix Pharmaceuticals' Growth

Warner Chilcott Shares Plunged: What You Need to Know

Where Amgen Is Finding Its Growth

The 20 Fastest Growers in Pharma

US Stock Futures: HOT STOCKS TO WATCH

Mid-Day Update: Stocks Sell Off Sharply on Fed Move, European Worries

Stock Slide Steepens as Broad Economic Concerns Sack Investor Confidence

Warner Chilcott Shares Popped: What You Need to Know

FDA Panel: Won't Make Treatment Recommendation For Osteoporosis Drugs

Are Shorts Watching This Number at Novo Nordisk?

3 Stocks Near 52-Week Lows Worth Buying

Here's How Novo Nordisk A/S Is Making You So Much Cash

Warner Chilcott 2Q Net Off 38% On Lower Actonel Sales, Restructuring

Warner Chilcott PLC's CEO Discusses Q2 2011 Results - Earnings Conference Call

Is Salix Pharmaceuticals Hiding Weakness?

Why Medicis Pharmaceutical May Be About to Take Off

Takeover Target? BioSante Attracts Deal Talks With Female Sex Drug

FDA Panel To Discuss Safety Of Osteoporosis Drugs

After Savvis Deal, What Is SAC Capital's Steven Cohen Buying?

Top Pharma Stocks That Hedge Funds Love

D.E. Shaw's Favorite Long Term Stock Picks

A Look at Citi Investment Research's Top Mid Cap Buy Recommendations

15 Stocks Sending a Bearish Signal

See More Articles...